Implantable Drug Delivery Devices Market by Material, Product Type and End User : Global Opportunity Analysis and Industry Forecast, 2019-2027

Title:
Implantable Drug Delivery Devices Market by Material (Silicon and Others), Product Type (Implantable Drug Eluting Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Brachytherapy Seeds Devices, and Implantable Drug Delivery Pump Devices) and End User (Hospitals, Ambulatory Surgery Center, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027.

The global implantable drug delivery devices market was valued at $10,091.9 million in 2019, and is projected to reach $13,211.8 million by 2027 at a CAGR of 8.0% from 2020 to 2027.

Implantable drug delivery devices consist of a drug reservoir surrounded by a polymer or a drug polymer mixture. When inserted into a desired area in the body, the drug is released at a pre-determined rate as the polymer degrades. Implantable drug delivery devices offer a number of advantages over conventional oral or parenteral dosage forms. It allows site specific drug administration where a drug is most needed.

This allows significant lower doses of drugs, which minimize potential side effects. Furthermore, implantable devices allow for sustained release of a therapeutic agent. In addition, treatment schedule associated with an implantable device is generally less burdensome than pills or injections.

Growth of the implantable drug delivery devices market is driven by rise in prevalence of chronic diseases across the globe, increase in demand for minimally invasive drug delivery devices, and unwanted pregnancies over a period. However, possibility of implanted device failures, and stringent government regulations impede the market growth. Conversely, collaboration activities among leading market players are expected to provide lucrative growth opportunities for the market.

The implantable drug delivery devices market is segmented into material, product type, end user, and region. By material, the market is divided into silicon and others. On the basis of product type, implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• This report entails a detailed quantitative analysis of the current market trends from 2019 to 2027 to identify prevailing opportunities along with strategic assessment of the global Implantable Drug Delivery Devices market.
• Market size and estimations are based on a comprehensive analysis of end users, developments, and services in the industry.
• An in-depth analysis based on region assists to understand the regional market and facilitates strategic business planning.
• Developmental strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Material

• Silicon
• Others

By Product Type

• Implantable Drug Eluting Stents
• Implantable Contraceptive Drug Delivery Devices
• Implantable Intraocular Drug Delivery Devices
• Implantable Brachytherapy Seeds Devices
• Implantable Drug Delivery Pump Devices

By End User

• Hospitals
• Ambulatory Surgery Centers
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
•  

KEY MARKET PLAYERS

• Abbott Laboratories
• AbbVie Inc
• Bayer AG
• Bausch Health Companies Inc.
• Biotronik, Inc.
• Boston Scientific Corporation
• Medtronic Plc.
• Merck & co., Inc.
• Teleflex Incorporated
• Terumo Corporation
• OTHER MARKET PLAYERS
• DSM Biomedical
• Alimera Sciences
• Eyepoint Pharmaceuticals
• Delpor Inc.
• 3M Company

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key benefits for stakeholders
• 1.3.Key market segments
• 1.4.List of key players profiled in the report
• 1.5.Research methodology
  • 1.5.1.Secondary research
  • 1.5.2.Primary research
  • 1.5.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
  • 3.2.2.Top winning strategies
• 3.3.Top player positioning, 2019
• 3.4.Porter's five forces analysis
• 3.5.Market dynamics
  • 3.5.1.Drivers
    • 3.5.1.1.Increase in prevalence of chronic diseases
    • 3.5.1.2.Rise in demand for minimally invasive drug delivery devices
    • 3.5.1.3.Unwanted pregnancies
  • 3.5.2.Restraints
    • 3.5.2.1.Possibility of implanted device failure
    • 3.5.2.2.Stringent government regulations
  • 3.5.3.Opportunity
    • 3.5.3.1.Collaboration activities among leading players
  • 3.5.4.Impact analysis

CHAPTER 4:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL

• 4.1.Overview
  • 4.1.1.Market size and forecast
• 4.2.Silicone
  • 4.2.1.Key market trends, growth factors, and opportunities
  • 4.2.2.Market size and forecast, by region
  • 4.2.3.Market analysis, by country
• 4.3.Others
  • 4.3.1.Key market trends, growth factors, and opportunities
  • 4.3.2.Market size and forecast, by region
  • 4.3.3.Market analysis, by country

CHAPTER 5:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

• 5.1.Overview
  • 5.1.1.Market size and forecast
• 5.2.Implantable Drug Eluting Stents
  • 5.2.1.Market size and forecast, by region
  • 5.2.2.Market analysis, by country
• 5.3.Implantable Contraceptive Drug Delivery Devices
  • 5.3.1.Market size and forecast, by region
  • 5.3.2.Market analysis, by country
• 5.4.Implantable Intraocular Drug Delivery Devices
  • 5.4.1.Market size and forecast, by region
  • 5.4.2.Market analysis, by country
• 5.5.Implantable Brachytherapy Seeds Devices
  • 5.5.1.Market size and forecast, by region
  • 5.5.2.Market analysis, by country
• 5.6.Implantable Drug Delivery Pump Devices
  • 5.6.1.Market size and forecast, by region
  • 5.6.2.Market analysis, by country

CHAPTER 6:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER

• 6.1.Overview
  • 6.1.1.Market size and forecast
• 6.2.Hospitals
  • 6.2.1.Market size and forecast, by region
  • 6.2.2.Market analysis, by country
• 6.3.Ambulatory Surgery Centers
  • 6.3.1.Market size and forecast, by region
  • 6.3.2.Market analysis, by country
• 6.4.Others
  • 6.4.1.Market size and forecast, by region
  • 6.4.2.Market analysis, by country

CHAPTER 7:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY REGION

• 7.1.Overview
  • 7.1.1.Market size and forecast
• 7.2.North America
  • 7.2.1.Key market trends, growth factors, and opportunities
  • 7.2.2.North America implantable drug delivery devices market, by country
    • 7.2.2.1.U.S.
    • 7.2.2.1.1.Market size and forecast, by material
    • 7.2.2.1.2.Market size and forecast, by product type
    • 7.2.2.1.3.Market size and forecast, by end user
    • 7.2.2.2.Canada
    • 7.2.2.2.1.Market size and forecast, by material
    • 7.2.2.2.2.Market size and forecast, by product type
    • 7.2.2.2.3.Market size and forecast, by end user
    • 7.2.2.3.Mexico
    • 7.2.2.3.1.Market size and forecast, by material
    • 7.2.2.3.2.Market size and forecast, by product type
    • 7.2.2.3.3.Market size and forecast, by end user
  • 7.2.3.North America market size and forecast, by material
  • 7.2.4.North America market size and forecast, product type
  • 7.2.5.North America market size and forecast, by end user
• 7.3.Europe
  • 7.3.1.Key market trends, growth factors, and opportunities
  • 7.3.2.Europe implantable drug delivery devices market, by country
    • 7.3.2.1.Germany
    • 7.3.2.1.1.Market size and forecast, by material
    • 7.3.2.1.2.Market size and forecast, by product type
    • 7.3.2.1.3.Market size and forecast, by end user
    • 7.3.2.2.UK
    • 7.3.2.2.1.Market size and forecast, by material
    • 7.3.2.2.2.Market size and forecast, by product type
    • 7.3.2.2.3.Market size and forecast, by end user
    • 7.3.2.3.France
    • 7.3.2.3.1.Market size and forecast, by material
    • 7.3.2.3.2.Market size and forecast, by product type
    • 7.3.2.3.3.Market size and forecast, by end user
    • 7.3.2.4.Italy
    • 7.3.2.4.1.Market size and forecast, by material
    • 7.3.2.4.2.Market size and forecast, by product type
    • 7.3.2.4.3.Market size and forecast, by end user
    • 7.3.2.5.Spain
    • 7.3.2.5.1.Market size and forecast, by material
    • 7.3.2.5.2.Market size and forecast, by product type
    • 7.3.2.5.3.Market size and forecast, by end user
    • 7.3.2.6.Rest of Europe
    • 7.3.2.6.1.Market size and forecast, by material
    • 7.3.2.6.2.Market size and forecast, by product type
    • 7.3.2.6.3.Market size and forecast, by end user
  • 7.3.3.Europe market size and forecast, by material
  • 7.3.4.Europe market size and forecast, product type
  • 7.3.5.Europe market size and forecast, by end user
• 7.4.Asia-Pacific
  • 7.4.1.Key market trends, growth factors, and opportunities
  • 7.4.2.Asia-Pacific implantable drug delivery devices market, by country
    • 7.4.2.1.China
    • 7.4.2.1.1.Market size and forecast, by material
    • 7.4.2.1.2.Market size and forecast, by product type
    • 7.4.2.1.3.Market size and forecast, by end user
    • 7.4.2.2.Japan
    • 7.4.2.2.1.Market size and forecast, by material
    • 7.4.2.2.2.Market size and forecast, by product type
    • 7.4.2.2.3.Market size and forecast, by end user
    • 7.4.2.3.Australia
    • 7.4.2.3.1.Market size and forecast, by material
    • 7.4.2.3.2.Market size and forecast, by product type
    • 7.4.2.3.3.Market size and forecast, by end user
    • 7.4.2.4.India
    • 7.4.2.4.1.Market size and forecast, by material
    • 7.4.2.4.2.Market size and forecast, by product type
    • 7.4.2.4.3.Market size and forecast, by end user
    • 7.4.2.5.South Korea
    • 7.4.2.5.1.Market size and forecast, by material
    • 7.4.2.5.2.Market size and forecast, by product type
    • 7.4.2.5.3.Market size and forecast, by end user
    • 7.4.2.6.Rest of Asia-Pacific
    • 7.4.2.6.1.Market size and forecast, by material
    • 7.4.2.6.2.Market size and forecast, by product type
    • 7.4.2.6.3.Market size and forecast, by end user
  • 7.4.3.Asia-Pacific market size and forecast, by material
  • 7.4.4.Asia-Pacific market size and forecast, product type
  • 7.4.5.Asia-Pacific market size and forecast, by end user
• 7.5.LAMEA
  • 7.5.1.Key market trends, growth factors, and opportunities
  • 7.5.2.LAMEA implantable drug delivery devices market, by country
    • 7.5.2.1.Brazil
    • 7.5.2.1.1.Market size and forecast, by material
    • 7.5.2.1.2.Market size and forecast, by product type
    • 7.5.2.1.3.Market size and forecast, by end user
    • 7.5.2.2.Saudi Arabia
    • 7.5.2.2.1.Market size and forecast, by material
    • 7.5.2.2.2.Market size and forecast, by product type
    • 7.5.2.2.3.Market size and forecast, by end user
    • 7.5.2.3.South Africa
    • 7.5.2.3.1.Market size and forecast, by material
    • 7.5.2.3.2.Market size and forecast, by product type
    • 7.5.2.3.3.Market size and forecast, by end user
    • 7.5.2.4.Rest of LAMEA
    • 7.5.2.4.1.Market size and forecast, by material
    • 7.5.2.4.2.Market size and forecast, by product type
    • 7.5.2.4.3.Market size and forecast, by end user
  • 7.5.3.LAMEA market size and forecast, by material
  • 7.5.4.LAMEA market size and forecast, product type
  • 7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

• 8.1.ABBOTT LABORATORIES
  • 8.1.1.Company overview
  • 8.1.2.Company snapshot
  • 8.1.3.Operating business segments
  • 8.1.4.Product portfolio
  • 8.1.5.Business performance
  • 8.1.6.Key strategic moves and developments
• 8.2.ABBVIE INC.
  • 8.2.1.Company overview
  • 8.2.2.Company snapshot
  • 8.2.3.Operating business segments
  • 8.2.4.Product portfolio
  • 8.2.5.Business performance
  • 8.2.6.Key strategic moves and developments
• 8.3.Bayer AG.
  • 8.3.1.Company overview
  • 8.3.2.Company snapshot
  • 8.3.3.Operating business segments
  • 8.3.4.Product portfolio
  • 8.3.5.Business performance
• 8.4.BAUSCH HEALTH COMPANIES INC.
  • 8.4.1.Company overview
  • 8.4.2.Company snapshot
  • 8.4.3.Operating business segments
  • 8.4.4.Product portfolio
  • 8.4.5.Business performance
• 8.5.BIOTRONIK, INC.
  • 8.5.1.Company overview
  • 8.5.2.Company snapshot
  • 8.5.3.Operating business segments
  • 8.5.4.Product portfolio
  • 8.5.5.Key strategic moves and developments
• 8.6.BOSTON SCIENTIFIC CORPORATION
  • 8.6.1.Company overview
  • 8.6.2.Company snapshot
  • 8.6.3.Operating business segments
  • 8.6.4.Product portfolio
  • 8.6.5.Business performance
  • 8.6.6.Key strategic moves and developments
• 8.7.MEDTRONIC PLC.
  • 8.7.1.Company overview
  • 8.7.2.Company snapshot
  • 8.7.3.Operating business segments
  • 8.7.4.Product portfolio
  • 8.7.5.Business performance
  • 8.7.6.Key strategic moves and developments
• 8.8.MERCK & CO., INC.
  • 8.8.1.Company overview
  • 8.8.2.Company snapshot
  • 8.8.3.Operating business segments
  • 8.8.4.Product portfolio
  • 8.8.5.Business performance
• 8.9.TELEFLEX INCORPORATED
  • 8.9.1.Company overview
  • 8.9.2.Company snapshot
  • 8.9.3.Operating business segments
  • 8.9.4.Product portfolio
  • 8.9.5.Business performance
• 8.10.TERUMO CORPORATION
  • 8.10.1.Company overview
  • 8.10.2.Company snapshot
  • 8.10.3.Operating business segments
  • 8.10.4.Product portfolio
  • 8.10.5.Business performance
  • 8.10.1.Key strategic moves and developments

LIST OF TABLES

• TABLE 01.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 02.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR SILICON, BY REGION, 2019-2027 ($MILLION)
• TABLE 03.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
• TABLE 04.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 05.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 (THOUSAND UNITS)
• TABLE 06.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE DRUG ELUTING STENTS, BY REGION, 2019-2027 ($MILLION)
• TABLE 07.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE CONTRACEPTIVE DRUG DELIVERY DEVICES, BY REGION, 2019-2027 ($MILLION)
• TABLE 08.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE INTRAOCULAR DRUG DELIVERY DEVICES, BY REGION, 2019-2027 ($MILLION)
• TABLE 09.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE BRACHYTHERAPY SEEDS DEVICES, BY REGION, 2019-2027 ($MILLION)
• TABLE 10.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE DRUG DELIVERY PUMP DEVICES, BY REGION, 2019-2027 ($MILLION)
• TABLE 11.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 12.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
• TABLE 13.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS , BY REGION, 2019-2027 ($MILLION)
• TABLE 14.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
• TABLE 15.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
• TABLE 16.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
• TABLE 17.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 18.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 19.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 20.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 21.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 22.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 23.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 24.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 25.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 26.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 27.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 28.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 29.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
• TABLE 30.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 31.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 32.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 33.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 34.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 35.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 36.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 37.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 38.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 39.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 40.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 41.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 42.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 43.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 44.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 45.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 46.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 47.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 48.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 49.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 50.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 51.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
• TABLE 52.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 53.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 54.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 55.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 56.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 57.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 58.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 59.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 60.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 61.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 62.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 63.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 64.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 65.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 66.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 67.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 68.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 69.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 70.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 71.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 72.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 73.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
• TABLE 74.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 75.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 76.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 77.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 78.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 79.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 80.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 81.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 82.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019-2027 ($MILLION)
• TABLE 83.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 84.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 85.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 86.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019-2027 ($MILLION)
• TABLE 87.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
• TABLE 88.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019-2027 ($MILLION)
• TABLE 89.ABBOTT: COMPANY SNAPSHOT
• TABLE 90.ABBOTT: OERATING SEGMENT
• TABLE 91.ABBOTT: PRODUCT PORTFOLIO
• TABLE 92.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 93.ABBVIE: COMPANY SNAPSHOT
• TABLE 94.ABBVIE: OERATING SEGMENT
• TABLE 95.ABBVIE: PRODUCT PORTFOLIO
• TABLE 96.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 97.BAYER: COMPANY SNAPSHOT
• TABLE 98.BAYER: OPERATING SEGMENTS
• TABLE 99.BAYER: PRODUCT PORTFOLIO
• TABLE 100.BAUSCH: COMPANY SNAPSHOT
• TABLE 101.BAUSCH: OPERATING SEGMENTS
• TABLE 102.BAUSCH: PRODUCT PORTFOLIO
• TABLE 103.BIOTRONIK: COMPANY SNAPSHOT
• TABLE 104.BIOTRONIK: OPERATING SEGMENTS
• TABLE 105.BIOTRONIK: PRODUCT PORTFOLIO
• TABLE 106.BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
• TABLE 107.BOSTON: COMPANY SNAPSHOT
• TABLE 108.BOSTON: OPERATING SEGMENTS
• TABLE 109.BOSTON: PRODUCT PORTFOLIO
• TABLE 110.MEDTRONIC: COMPANY SNAPSHOT
• TABLE 111.MEDTRONIC: OPERATING SEGMENTS
• TABLE 112.MEDTRONIC: PRODUCT PORTFOLIO
• TABLE 113.MERCK: COMPANY SNAPSHOT
• TABLE 114.MERCK: OPERATING SEGMENTS
• TABLE 115.MERCK PRODUCT PORTFOLIO
• TABLE 116.TELEFLEX: COMPANY SNAPSHOT
• TABLE 117.TELEFLEX: OERATING SEGMENT
• TABLE 118.TELEFLEX: PRODUCT PORTFOLIO
• TABLE 119.TERUMO: COMPANY SNAPSHOT
• TABLE 120.TERUMO: OERATING SEGMENT
• TABLE 121.TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

• FIGURE 01.IMPLANTABLE DRUG DELIVERY DEVICES MARKET SEGMENTATION
• FIGURE 02.TOP INVESTMENT POCKETS
• FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2020 *
• FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020 (%)
• FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020
• FIGURE 06.TOP PLAYER POSITIONING, 2019
• FIGURE 07.MODERATE BARGANING POWER OF SUPPLIERS
• FIGURE 08.MODERATE BARGAINING POWER OF BUYERS
• FIGURE 09.MODERATE THREAT OF NEW ENTRANT
• FIGURE 10.MODERATE THREAT OF SUBSTITUTION
• FIGURE 11.MODERATE COMPETITIVE RIVALRY
• FIGURE 12.IMPACT ANALYSES
• FIGURE 13.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY SILICON MARKET, 2019-2027 ($MILLION)
• FIGURE 14.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY OTHER, BY REGION, 2019-2027 ($MILLION)
• FIGURE 15.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE DRUG ELUTING STENTS MARKET, 2019-2027 ($MILLION)
• FIGURE 16.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE CONTRACEPTIVE DRUG DELIVERY DEVICES, 2019-2027 ($MILLION)
• FIGURE 17.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE INTRAOCULAR DRUG DELIVERY DEVICES, 2019-2027 ($MILLION)
• FIGURE 18.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE BRACHYTHERAPY SEEDS DEVICES, 2019-2027 ($MILLION)
• FIGURE 19.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY DRUG DELIVERY PUMP DEVICES, 2019-2027 ($MILLION)
• FIGURE 20.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY HOSPITALS MARKET, 2019-2027 ($MILLION)
• FIGURE 21.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET , BY AMBULATORY SURGERY CENTERS , 2019-2027 ($MILLION)
• FIGURE 22.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY OTHER, 2019-2027 ($MILLION)
• FIGURE 23.ABBOTT: NET SALES, 2017-2019 ($MILLION)
• FIGURE 24.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 25.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
• FIGURE 26.ABBVIE: NET SALES, 2017-2019 ($MILLION)
• FIGURE 27.ABBVIE: REVENUE SHARE, BY REGION, 2019(%)
• FIGURE 28.BAYER: NET SALES, 2017-2019 ($MILLION)
• FIGURE 29.BAYER: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 30.BAYER: REVENUE SHARE, BY REGION, 2019 (%)
• FIGURE 31.BAUSCH: NET SALES, 2017-2019 ($MILLION)
• FIGURE 32.BAUSCH: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 33.BAUSCH: REVENUE SHARE, BY REGION, 2019 (%)
• FIGURE 34.BOSTON: NET SALES, 2017-2019 ($MILLION)
• FIGURE 35.BOSTON: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 36.BOSTON: REVENUE SHARE, BY REGION, 2019(%)
• FIGURE 37.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
• FIGURE 38.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 39.MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2019 (%)
• FIGURE 40.MERCK: NET SALES, 2017-2019 ($MILLION)
• FIGURE 41.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 42.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
• FIGURE 43.TELEFLEX: NET SALES, 2017-2019 ($MILLION)
• FIGURE 44.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 45.TELEFLEX: REVENUE SHARE, BY REGION, 2019 (%)
• FIGURE 46.TERUMO: NET SALES, 2017-2019 ($MILLION)
• FIGURE 47.TERUMO: REVENUE SHARE, BY SEGMENT, 2019 (%)
• FIGURE 48.TERUMO: REVENUE SHARE, BY REGION, 2019 (%)